2025 MIDD Webinar Series | MIDD for drug immunogenicity

Martin obtained his PhD in Pharmacometrics from Uppsala University. He has 20+ years of drug development experience in areas such as metabolic disorders, autoimmune disease, infectious disease, hematological disorders etc. In 2012 Martin co-founded the consulting company Pharmetheus AB. In the consultant role he has been engaged as strategic advisor on behalf of multiple clients and acted as the main responsible consultant for 50+ pharmacometric data analysis projects on behalf of more than 20 different clients. The projects have ranged from pre-clinical translational projects to submission ready large-scale phase III PKPD analysis. These analyses have among other things contributed to 5+ successful NDA filings. 

Gianluca obtained an M.Sc. in Biomedical engineering from University of Bologna, Italy, and Ph.D. in Bioengineering from the New University of Lisbon, Portugal. He is an expert in quantitative systems pharmacology (QSP) modelling spanning therapeutic areas such as oncology and immuno-inflammation. He has worked as a Senior Modeler at the Fondazione Microsoft Research – University of Trento Centre for Computational and Systems Biology. During his time at Pharmetheus he has among other things contributed to the development of a QSP framework for drug immunogenicity following subcutaneous administration.